ABC | Volume 115, Nº2, Agosto 2020

Comunicação Breve Martins-Filho et al. Biomarcadores cardíacos em pacientes com COVID-19 Arq Bras Cardiol. 2020; 115(2):273-277 1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):P1054-62. 2. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Mar 25. [Epub ahead of print]. 3. Bauchner H, Golub RM, Zylke J. Editorial concern-possible reporting of the same patients with COVID-19 in different reports. JAMA. 2020;323(13):1256. 4. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. 5. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):135. 6. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMCMed Res Methodol. 2005 Apr 20;5:13. 7. Cao J, TuWJ, Cheng W, Yu L, Liu YK, Hu X, et al. Clinical features and short- term outcomes of 102 patients with corona virus disease 2019 in Wuhan, China. Clin Infect Dis. 2020 Apr. [Epub ahead of print]. 8. Chen T, WuD, ChenH, YanW, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020 Mar 26;368:m1295. 9. Guo T, Fan Y, ChenM,Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020 Mar 27. [Epub ahead of print]. 10. Wang L, He W, Yu X, Hu D, Bao M, Liu H, et al. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020;80(6):639-45. 11. Zhang F, Yang D, Li J, Gao P, Chen T, Cheng Z, et al. Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: A single center retrospective cohort study. medRxiv. 2020;17:2020.03.21.20040121. 12. Elkind MSV, Harrington RA, Benjamin IJ. The role of the American Heart Association in the Global COVID-19 pandemic. Circulation. 2020;141(15):e743-45. 13. Ferrari R, Di Pasquale G, Rapezzi C. What is the relationship between Covid-19 and cardiovascular disease? Int J Cardiol. 2020 Jul 1;310:167-8. 14. Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. 2020;22(5):911-5. 15. Deng Q, Hu B, Zhang Y, Yan J, Ping H, Zhou Q, et al. Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China. Int J Cardiol. 2020 July 15;311:116-21. 16. TanW, Aboulhosn J. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease. Int J Cardiol. 2020 Jun 15;309:70-7. 17. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system. JAMA Cardiol. 2020 Mar 27. [Epub ahead of print]. 18. VaduganathanM, VardenyO, Michel T, McMurray JJ V, PfefferMA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020 Apr 23382:1653-9. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 277